Concepedia

Martin Mutonga

MM

6

Publications

234

Citations

6

H-Index

2014

Active since

Affiliations

University of Chicago(Current)

OncoTherapy Science (Japan)

University of Southern California

Martin Mutonga is an author at University of Chicago specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2014–2016

6

Publications

6

Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia

Houda Alachkar, Martin Mutonga, Klaus H. Metzeler et al. · Oncotarget · 2014 · 63 citations · Full text

Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia

Houda Alachkar, Noreen Fulton, B Sanford et al. · The Pharmacogenomics Journal · 2016 · 48 citations

, , +7

Management of Metastatic HER2-Positive Breast Cancer: Where Are We and Where Do We Go From Here?

Cesar A. Santa‐Maria, Lauren Nye, Martin Mutonga et al. · PubMed · 2016 · 42 citations

, , +18

Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection

Houda Alachkar, Martin Mutonga, Taigo Kato et al. · BMC Nephrology · 2016 · 39 citations · Full text

T-LAK cell-originated protein kinase presents a novel therapeutic target in<i>FLT3</i>-ITD mutated acute myeloid leukemia

Houda Alachkar, Martin Mutonga, Gregory Malnassy et al. · Oncotarget · 2015 · 22 citations · Full text

Rows per page

1–5 of 6